- BNTX -2.58%
BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript
Yahoo Finance · 2 hours ago
Open | 92.85 |
High | 93.23 |
Low | 90.75 |
Mkt Cap | 21.92B |
P/E (TTM) | 22.13 |
Div & Yield | N/A & N/A |
Prev. Close | 93.35 |
52 Wk. Low | 85.21 |
52 Wk. High | 125.83 |
Related stocks
Biotechnology company from Germany
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. Wikipedia
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | 1.48B | 65.40% ▼ |
Net Income | 457.9M | 79.90% ▼ |
Diluted EPS | -1.41 | 79.50% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$2.15 | - |
Q1 2024 | -$1.17 | -$1.41 |
Q4 2023 | $2.60 | $2.04 |
S&P 500^GSPC | 5,195.72+14.98 (+0.29%) |
Dow 30^DJI | 38,922.35+70.08 (+0.18%) |
Nasdaq^IXIC | 16,380.63+31.38 (+0.19%) |
104.88-9.95% | |
Datadog, Inc.DDOG | 114.04-10.18% |
10.29-0.39% |